Pharmaceutic preparation for treating chronic obstructive pulmonary disease

A technology of chronic obstructive pulmonary and pharmaceutical preparations, applied in the field of traditional Chinese medicine, can solve problems such as poor quality of life, intestinal flora imbalance, and short maintenance time, and achieve the effect of improving the cure rate, less adverse reactions, and good therapeutic effects

Inactive Publication Date: 2015-01-07
QINGDAO HUAREN TECH INCUBATOR
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In addition, although western medicine has definite curative effect on COPD, the long-term repeated use of broad-spectrum antibiotics, theophylline drugs and bronchodilators will cause damage to the gastric mucosal barrier, intestinal flora imbalance and shift, resulting in digestive and absorption dysfunction, etc. Side effects, and short duration
Therefore, the quality of life of patients after treatment is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutic preparation for treating chronic obstructive pulmonary disease
  • Pharmaceutic preparation for treating chronic obstructive pulmonary disease
  • Pharmaceutic preparation for treating chronic obstructive pulmonary disease

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0032] The present invention also provides a preparation method of the above-mentioned pharmaceutical preparation, when the prepared pharmaceutical preparation is a granule, specifically:

[0033] The first step is to take sealwort, Gorgon fruit, barley ginseng, asparagus, northern sand ginseng and black lotus, grind them separately, mix according to the above weight, and dissolve the evenly mixed mixture in ethanol with an alcohol concentration of 85% to 95% , the amount of ethanol added per 100g of the mixture is 300g, soaked for 24 hours to 36 hours, then slowly percolated at a rate of 1 to 2ml per minute by percolation method, collected percolation liquid, and allowed to stand overnight, Filtrate, remove the solvent from the filtrate, pulverize and dry to obtain the first powder;

[0034] Step 2: Cinnamon twigs, Fritillaria fritillaria, Hundred eyes, Baijiucao, Anemarrhena, and Trichosanthes were crushed separately, mixed according to the above weight, and the mixed mixtur...

Embodiment 1

[0070] Example 1 Granule 1

[0071] Take 35g of sealwort, 25g of gorgon, 30g of ginseng, 40g of asparagus, 35g of northern sand ginseng and 30g of Eclipta chinensis, and mix them, and dissolve the evenly mixed mixture in ethanol with an alcohol concentration of 95%. The amount of ethanol added is 300g, soaked for 24 hours, then slowly percolated at a rate of 2ml per minute by percolation method, collected percolation liquid, left standing overnight for percolation liquid, filtered, solvent removed from filtrate, crushed and dried To obtain the first powder, 20g of cassia twigs, 25g of Fritillaria fritillaria, 20g of Baiyanteng, 25g of Baijiucao, 30g of Anemarrhena anemarrhena, and 15g of Trichosanthes mellifera are respectively pulverized and mixed, and each 100g of the obtained mixed mixture is put into 400ml of alcohol In liquor with a temperature of 50°C to 60°C, seal and soak for 20 days, then boil for 3 hours, let stand for 12 hours, filter, and concentrate the obtained f...

Embodiment 2

[0072] Example 2 Granules 2

[0073] Take 30g of sealwort, 20g of gorgon, 30g of ginseng, 40g of asparagus, 35g of northern sand ginseng and 30g of Eclipta chinensis, and mix them separately. Dissolve the evenly mixed mixture in ethanol with an alcohol concentration of 95%. Each 100g of the mixture corresponds The amount of ethanol added is 300g, soaked for 24 hours, then slowly percolated at a rate of 2ml per minute by percolation method, collected percolation liquid, left standing overnight for percolation liquid, filtered, solvent removed from filtrate, crushed and dried To obtain the first powder, 15g of cassia twig, 20g of Fritillaria japonica, 15g of Baiyanteng, 25g of Baijiucao, 30g of Anemarrhena anemarrhena, and 15g of Trichosanthes mellifera are respectively pulverized and mixed, and each 100g of the obtained mixed mixture is put into 400ml of alcohol In liquor with a temperature of 50°C to 60°C, seal and soak for 20 days, then boil for 3 hours, let stand for 12 hour...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pharmaceutic preparation for treating chronic obstructive pulmonary disease. The pharmaceutic preparation is prepared from such medicinal raw materials as salvia miltiorrhiza, hairyvein agrimony, sealwort, curcuma zedoary, cassia twig, thunberg fritillary bulb, white mulberry root-bark, semen euryales, morinda parvifolia, spina gleditsiae, geranium wilfordii, downy aletris, silene conoidea, conyza japonica, radix asparagi, winter cherry, folium eriobotryae, rhizoma anemarrhenae, radix glehniae, ephedra, trichosanthes kirilowii maxim, morinda officinalis, frankincense, eclipta and hippophae rhamnoides. The pharmaceutic preparation for treating chronic obstructive pulmonary disease is good in curative effect, capable of increasing the cure rate of patients, low in adverse reaction and worthy of popularization and application.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical preparation for treating chronic obstructive pulmonary disease. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is a common disease of the respiratory system that can be prevented and treated. It is characterized by persistent airflow limitation and progressive development. The prevalence of COPD is high and the social and economic burden is increasing. Therefore, the effective prevention and treatment of COPD has become an important public health problem. It is currently the sixth deadliest disease in the world. The World Health Organization (WHO) predicts that by 2020, it will become the world's The disease with the fifth largest burden in the range. [0003] At present, it is generally believed that COPD is mainly characterized by chronic inflammation of the airway, lung parenchyma and pulmonary blood vessels, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P11/00
CPCA61K36/9066A61K9/1623A61K9/4866A61K36/17A61K36/185A61K36/23A61K36/28A61K36/324A61K36/36A61K36/428A61K36/483A61K36/53A61K36/537A61K36/54A61K36/605A61K36/62A61K36/73A61K36/746A61K36/896A61K36/8964A61K36/8965A61K36/8966A61K36/8969A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2300/00
Inventor 不公告发明人
Owner QINGDAO HUAREN TECH INCUBATOR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap